In patients with NASH, TGF-β can be produced by Kupffer cells (liver macrophages), which also activates HSCs and boosts liver fibrosis, with phagocytosis of apoptotic bodies as mediators of HSCs’ activation and fibrogenesis advancement [35,36]. This evidence concerns the gene TGFB1 and Hepatic fibrosis.